Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Lomitapide in Healthy Subjects.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02080455
Recruitment Status : Completed
First Posted : March 6, 2014
Last Update Posted : March 24, 2015
Information provided by (Responsible Party):
Aegerion Pharmaceuticals, Inc.

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Completed
Actual Primary Completion Date : March 2014
Actual Study Completion Date : October 2014
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 June 23, 2015
July 17, 2015
2 February 9, 2018
October 26, 2018
3 February 25, 2020